Significant functional differences in differentiated Conditionally Reprogrammed (CRC)- and Feeder-free Dual SMAD inhibited-expanded human nasal epithelial cells-Reference-Cited by-同舟云学术

Significant functional differences in differentiated Conditionally Reprogrammed (CRC)- and Feeder-free Dual SMAD inhibited-expanded human nasal epithelial cells

Published:2021-03 Issue:2 Volume:20 Page:364-371
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Awatade Nikhil T.,Wong Sharon L.,Capraro Alexander^ORCID,Pandzic Elvis,Slapetova Iveta,Zhong Ling,Turgutoglu Nihan,Fawcett Laura K.,Whan Renee M.,Jaffe Adam^ORCID,Waters Shafagh A.

Funder

Cystic Fibrosis in Australia

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference42 articles.

1. Cystic fibrosis;Ratjen;Nature reviews Disease primers,2015

2. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR;Wainwright;The New England journal of medicine,2015

3. Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR;Donaldson;American journal of respiratory and critical care medicine,2018

4. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770;Van Goor;Proceedings of the National Academy of Sciences of the United States of America,2009

5. VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles;Davies;The New England journal of medicine,2018

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells;Nature Communications;2024-08-28

2. Uncovering strain- and age-dependent innate immune responses to SARS-CoV-2 infection in air-liquid-interface cultured nasal epithelia;iScience;2024-06

3. Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model Platform to Validate Repurposed Drugs Against SARS-CoV-2 Infection;2024-05-23

4. Genome-Wide CRISPR-Cas9 Screening Identifies a Synergy between Hypomethylating Agents and SUMOylation Blockade in MDS/AML;2024-04-18

5. Human Nasal Epithelium Organoids for Assessing Neutralizing Antibodies to a Protective SARS-CoV-2 Virus-like Particle Vaccine;Organoids;2024-02-01